Section of Cardiovascular Pharmacotherapy
MEMBERS
The Section of Cardiovascular Pharmacotherapy
was established in 1983 in the Department of Pharmacy Practice at the College of Pharmacy. Members of the Section
hold academic appointments in both the College of Pharmacy and the College of Medicine (Section of Cardiology,
Department of Medicine) at UIC. They are responsible for research and scholarly activities relating to the clinical use,
safety and efficacy of drugs used for cardiovascular disease. Members are also responsible for instruction to pharmacy,
medical and nursing students and collaborative clinical pharmacy practice in a variety of specialty areas within cardiology. |
Director: Jerry L. Bauman,
PharmD, FCCP, FACC, Professor, Departments of Pharmacy Practice and Medicine (Cardiology)Dean; , College of Pharmacy |
|
Larisa Cavallari, PharmD, Associate Professor |
|
Robert DiDomenico, PharmD,
Clinical Assistant Professor |
|
Vicki Groo, PharmD,
Clinical Assistant Professor |
|
Edith Nutescu, PPharmD,
Clinical Associate Professor and Director, Antithrombosis Center |
|
Marieke D. Schoen, PharmD,
Clinical Associate Professor |
EXAMPLES OF RECENT PAPERS:
| Cavallari LH, Groo VL, Viana MAG, Dai Y, Patel SR, Stamos TD. Association of aldosterone concentration and mineralocorticoid receptor genotype with potassium response to spironolactone in patients with heart failure. Pharmacotherapy 2010 Jan;30(1):1-9. Cavallari LH, Langaee TY, Momary KM, Shapiro NL, Nutescu EA, Coty WA, Viana MAG, Patel SR, Johnson JA. Genetic and clinical predictors of warfarin dose requirements in African Americans. Clin Pharmacol Ther 2010 Apr;87(4):459-64. Limdi NA, Wadelius M, Cavallari L, Eriksson N, Crawford D, Lee MM, Chen CH, Motsinger-Rief A, Sagreiya H, Liu N, Wu AHB, Gage BR, Jorgensen A, Pirmohamed M, Shin JG, Suarez-Kurtz G, Kimmel SE, Johnson JA, Klein TE, Wagner MJ on behalf of the IWPC. Warfarin pharmacogenetics: VKORC1 genotype as predictive as haplotype across three racial groups. Blood 2010 May 6;115(18):3827-34. PMCID: PMC2865873. Perera MA, Gamazon E, Cavallari LH, Patel SR, Flynn M, Poindexter S, Kittles RA, Nicolea, D, Cox NJ. The missing association: sequenced-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans. Clin Pharmacol Ther 2011 Mar;89(3):408-15. Cavallari LH, Momary KM, Patel SR, Shapiro NL, Nutescu EA, Viana MAG. Pharmacogenomics of warfarin dose requirements in Hispanics. Blood Cells Mol Diseases 2011;46:147–50. Cavallari LH, Butler C, Langaee TY, Wardak N, Patel SR, Viana MAG, Shapiro NL, Nutescu EA. Apolipoprotein E genotype association with time to stable warfarin dosing in African Americans. Pharmacotherapy 2011 Aug;8(31):785-92. PMID: 21923605 Cavallari LH, Perera M, Wadelius M, Deloukas P, Taube G, Patel SR, Aquino-Michaels K, Viana MA, Shapiro NL, Nutescu EA. Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans. Pharmacogenet Genomics 2012 Feb;22(2):152-8. |
|
1983-84 Rick A. Barbarash, PharmD, FCCP |
|
1984-85 Bruce J. Schrader, PharmD, FCCP |
|
1985-86 Steven I. Berk, PharmD, MD |
|
1986-88 Nada S. Berry, PharmD |
|
1987-89 Patrick L. McCollam, PharmD |
|
1987-89 Robert B. Parker, PharmD, FCCP |
|
1988-89 Vicky L. Just, PharmD |
|
1988-90 Marieke D. Schoen, PharmD |
|
1989-90 Jon E. Folstad, PharmD |
|
1990-92 Deborah Tworek Piscitelli, PharmD |
|
1990-93 Sheila A. Roberts, PharmD |
|
1991-93 Jeffrey J. Grawe, PharmD |
|
1991-93 Allison P. Winecoff, PharmD |
|
1992-94 Kristin C. Oberg, PharmD |
|
1993-95 Bradley G. Phillips, PharmD |
|
1994-96 Ashesh J. Gandhi, PharmD |
|
1996-97 Mary Ross Southworth, PharmD |
|
1996-98 Cynthia A. Sanoski, PharmD |
|
1997-99 Robert J. DiDomenico, PharmD |
|
2001-02 Maria Tanzi, PharmD |
PAST STUDENTS AND GENERAL RESIDENTS:
|
1983-85 |
Mark Munger, PharmD, FCCP |
|
1984-86 |
Tim Hoon, PharmD |
|
1988-90 |
Eric Stanek, PharmD |
|
1992-93 |
Dawn Bell, PharmD |
|
1995 |
Dawn Zaremski Donna Leslie Lynette Moser |